[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"device-adherence\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:device-adherence":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100558832","effectiveness-of-a-digital-platform-in-engagement-and-prognosis-of-patients-in-an-early-intervention-pychosis-programme-100558832",false,"NCT06556251","Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme","Evaluating the Effectiveness of a Digital Platform in the Engagement and Prognosis of Patients in the Early Intervention Programme in Psychosis","Inclusion criteria:\n\n* Age between 18 and 40 years\n* Fulfil the criteria for one of the three groups (First Psychotic Episodes, Critical Period or Ultra High Risk of Psychosis; UHR)\n* To undergo community-based treatment as part of one of our facility's early intervention programmes for psychosis\n* Have signed the informed consent form for the study.\n\nExclusion criteria:\n\n* No mobile phone\u002Flaptop\u002Ftablet to use the platform.\n* Lack of skills and\u002For knowledge to use the platform.\n* Not have knowledge of the Catalan or Spanish language.\n* Have a diagnosed mental disability (premorbid Intelligence Quotient \\\u003C70).\n* Have had a medical condition that better explains the psychotic symptoms.","ALL","18 Years","40 Years",{"count":20,"type":21},128,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a randomised, prospective, controlled trial in which one group (experimental group; GE) receives access to the PIPPEP (Intervention Programme for Early Psychosis) platform in addition to the treatment as usual (TAU) in PIPPEP, while the other group (control group; GC) receives only TAU in PIPPEP.\n\nMain objective:\n\n\\- To assess whether the use of the PIPPEP platform improves psychosocial and pharmacological treatment adherence in mental health programmes.\n\nSecondary objectives:\n\n* To assess the cost-effectiveness of the PIPPEP app.\n* Evaluation of the dissemination of the platform.\n* To assess the clinical and functional outcomes of patients using the PIPPEP platform in terms of 1) positive symptoms, 2) side effects of antipsychotic medication, 3) perceived social self-stigma, 4) risk assessment, 5) comorbid symptoms and 6) social functioning\n\nThe participants are 1) between 18 and 40 years of age, who are being treated in one of the PIPPEP programmes for early intervention in psychosis at Sanitary Parc Sant Joan de Déu and who meet the inclusion criteria \"extremely high risk of psychosis\", \"critical phase or \"first psychotic episode\" and 2) agree to participate in the study and sign the informed consent form.",[27],"Device Adherence",[29,30,31,32,33],"platform","technologies","young people","early psychosis","adherence","RECRUITING","2025-05-20",{"date":37,"type":38},"2025-05-25","ACTUAL",{"date":40,"type":38},"2024-09-18",{"date":42,"type":21},"2027-12-31",{"name":44,"class":45},"Fundació Sant Joan de Déu","OTHER"]